# D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

> **NCT00264277** · PHASE4 · COMPLETED · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 600 (—)

## Conditions studied

- Deep Vein Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Vitamin K antagonist (Coumarin anticoagulants)

## Key facts

- **NCT ID:** NCT00264277
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2004-12
- **Final completion:** 2005-09
- **Target enrollment:** 600 (—)
- **Last updated:** 2021-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264277, "D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00264277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*